A B S T R A C T Cultured leukemic T and null lymphocytes are highly sensitive to growth inhibition by thymidine, as well as the other deoxynucleosides, deoxyguanosine and deoxyadenosine. By contrast, Epstein-Barr virus-transformed B lymphocytes are relatively resistant to deoxynucleosides. Growth inhibition is associated with the development of high deoxyribotriphosphate pools after exposure to the respective deoxynucleosides. We show that malignant T and null lymphocytes are deficient in ecto-ATPase activity. We show this cell surface enzyme to be of broad specificity, capable of degrading both ribotriphosphates and deoxyribotriphosphates. High levels of this ecto-enzyme are found in deoxynucleosideresistant, Epstein-Barr virus-transformed B lymphocytes. Ecto-ATPase deficiency may represent a mechanism for increased sensitivity to deoxynucleoside growth inhibition.
INTRODUCTION
The arrest of cell growth by millimolar concentrations of thymidine (TdR) is well established. The mechanism of this effect is believed to reflect inhibition of DNA replication by an increase in the cellular dTTP pool, which allosterically inhibits ribonucleotide reductase. This results in depression of the dCTP pool below a level critical for continued DNA replication (1) .
More recently there has been interest in the clinical use of TdR as an antitumor agent following demonstration that TdR could inhibit human tumor xenografts in nude mice (2) (3) (4) . We and others have reported that cultured leukemic lymphocytes of T and null cell type are extremely sensitive to growth inhibi-544 tion by TdR at concentrations two orders of magnitude below millimolar levels. The mechanisms of this increased sensitivity appear to reflect the ability of these leukemic cells to accumulate excess dTTP at low concentrations of exogenous TdR (5) (6) (7) .
These malignant cells are also similarly sensitive to low concentrations of deoxyguanosine (GdR) and deoxyadenosine (AdR). Again, the mechanisms of this inhibition appear to relate to accumulation of the triphosphates of these deoxynucleosides. An analogy has been drawn between the phenomena of deoxynucleoside-sensitive T and null leukemic cells and the immune-deficiency syndromes associated with adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiency. These defects in nucleoside catabolism result in accumulation of high levels of deoxyribonucleoside triphosphates (dNTP) dATP in ADA deficiency and dGTP in PNP deficiency.
It has been postulated that these excess dNTP act as feedback inhibitors of ribonucleotide reductase, causing inhibition of DNA replication in lymphocyte precursors, resulting in immune defects (5, 7, 8 Deoxynucleoside inhibition of cell growth. This was performed as previously described by us (6) .
DNA polymerase assay for deoxynucleoside triphosphates. This was performed as previously described by us (13) except that cells were extracted with 60% ethanol rather than 60% methanol. This assay is a modification of the methods described by Solter and Handschumacher (14) and Lindberg and Skoog (15) . Results are the means of duplicate assays.
Cytochemical stain for ATP triphosphatase. This was done by a modification of the method ofWachstein and Meisel (16) . Cells were harvested by spinning onto glass slides using a cytocentrifuge (Shandon Southern Instruments Ltd., Frimley, Surrey, Eng.).
The slides were air dried and incubated in the reaction mixtures at 37°C for 1 h. After incubation the slides were rinsed in water, immersed in 0.2% aqueous ammonium sulphide for 1 min, water washed, and then rinsed in methanol for 30 s. The cell nuclei were counter-stained in a methylene blue solution (0.005%) in 0.005% borax and then rinsed in water and air dried.
TdR uptake studies. These were performed as described by Cohen et al. (17) . 2 ml of cells in the log-growth phase (0.5 x 106 cells/ml) were incubated in quadruplicate with 10 ,uM [methyl-3H]TdR (50 mCi/mol) at 370C in culture medium for 30 min. The incubation was terminated by addition of 10 ml of cold phosphate-buffered saline, and the cells were washed three times with this cold phosphate-buffered saline. The cells were pelleted by centrifugation, and then lysed by addition of 0.5 ml of 2 N HC1I4. 200-,ul aliquots were then counted in Aquasol.
RESULTS
Role of TdR kinase in TdR sensitivity. We have previously shown that sensitivity to TdR varied some 200-fold among different types of cultured human lymphocytes (6) . The inhibitory dose (50%) (ID50) of nonmalignant EBV-transformed lines was -2 mM TdR (0.5-5), whereas acute lymphoblastic leukemic lines of T and null cell type were much more sensitive (ID50-
10-200 ,M).
We studied an additional leukemic line ofT cell type (JM), which was found to be resistant to growth inhibition by TdR. Its ID50 for TdR was 1.7 mM, a level similar to that of EBV-transformed peripheral blood B lymphocytes, but was 100-200-fold higher than that of TdR-sensitive cultured T and null cell leukemic lines (Table I) .
TdR kinase activity was assayed in extracts of the various lymphocyte cell lines. The activity in the TdRresistant T cell line (JM) was almost undetectable (0.2 nmol/mg per h) compared with the levels in the TdR-sensitive T and null cell lines (mean 11.47±7.16).
However, the resistant EBV-transformed B cell lines had TdR kinase activity levels similar to those of the TdR-sensitive T and null cell lines (Table I) kinase level similar to the other TdR-sensitive T cell lines (Table I) . Effect of TdR on the dTTP pools ofcultured lymphocytes. The various cell lines were incubated with TdR (50 ,uM) for 24 h, and then the dTTP pools were assayed. The T and null leukemic lines showed marked elevation of their dTTP pools; however, the EBV B cell lines failed to elevate their dTTP pool (Table II) . In contrast, little change was seen in the dTTP pools ofthe TdR-resistant TdR kinase-deficient T cell line (JM) ( Table III) . TdR monophosphate kinase. TdR monophosphate kinase activity, measured by the conversion ofdTMP to dTDP and dTTP, was similar in the TdR-sensitive T cell line (CEM) with a value of 57 nmol/h per mg protein, and 36 nmol/h per mg protein in the TdR-resistant B cell line (LAZ).
Relationship of TdR sensitivity to deoxyguanosine and deoxyadenosine sensitivity. As well as being extremely sensitive to growth inhibition by TdR, the cultured leukemic lymphocytes of T and null type were sensitive to GdR and AdR, though resistant to CdR. The growth of EBV-transformed peripheral blood B lymphocytes was not inhibited by these deoxynucleosides (Table IV) . The leukemic T cell lines showed increased sensitivity to deoxyadenosine if treated with the ADA inhibitor EHNA.
Following exposure to growth-inhibitory concentrations of GdR or AdR (in the presence of EHNA), there was a rapid rise in the intracellular pool of dGTP or The cell lines were cultured as described and then incubated with 50 ,uM TdR for 24 h, and the cells harvested by centrifugation. The dTTP pools were then assayed by the DNA polymerase method. Control dTTP pool variation during the incubation period was +8%.
dATP, respectively, in a T cell line compared with little change in a B cell line. This was similar to the rise in dTTP level after incubation with TdR (Table  V) . These elevated levels of dNTP fell, after the cells were resuspended in fresh media, to control levels by 48-72 h. Degradation of dTTP by cultured lymphocytes. The breakdown of dTTP by a leukemic T cell line (CCRF-CEM) and an EBV B cell line (LAZ 007) was studied using cells disrupted by sonication. There was rapid degradation ofdTTP, via dTDP, to dTMP by sonicated LAZ 007 line (1.5 x 105 cells/ml). There was < 1% We had previously noted, in a study of uptake of dNTP into EBV-transformed B lymphocytes made permeable by DEAE-dextran, that after incubation of intact cells with dTTP there was rapid extracellular degradation of dTTP via dTDP to dTMP (18) . This breakdown of dTTP appeared to represent activity of a cell surface phosphatase, since its activity was not reduced by washing the cells nor was enzyme activity found in the growth medium (18) . We therefore compared the breakdown of dTTP by sonicated LAZ 007 (EBV B lymphocytes) with intact cells (Fig. 1B) . The rate of degradation of dTTP was similar although slightly more rapid in the intact cells.
We subsequently studied the activity of this ectodTTPase in T, null, and B type cultured lymphocytes, as well as assayed the activity of ecto-ATPase (19) . The EBV-transformed B lymphocyte lines had high levels of ecto-triphosphatase activity using either ATP or dTTP as substrate (Table VI) . Activity ranged from [1] [2] [3] ,umol substrate consumed/106 cells per h. The malignant T and null cell lines, which were sensitive to deoxynucleosides, had very low levels of activity to both ATP and dTTP (<0.1 tkmol/106 cells per h). These differences were confirmed cytochemically by an ATPase stain (Fig. 2) . Levels of ecto-5'-nucleotidase, using AMP and dTMP as substrate, were also assayed in these cells. Higher activity was found in the null leukemic cell lines and the EBV-transformed B cell lines (Table VI) .
Characteristics of the EBV-transformed B lymphocyte ecto-triphosphatase. Some characteristics ofthis ecto-triphosphatase present in the EBV-transformed B lines were studied in the LAZ 007 cells. The Michaelis constants (KM) for ATP and dTTP were similar (-0.5 mM), and ATP could inhibit the degradation of dTTP and vice versa. It is not possible to demonstrate unequivocally whether these inhibitions were competitive or noncompetitive. This reflected difficulty in obtaining straight line initial rates, a feature of ectoenzymes kinetics previously noted (19) .
The LAZ 007 line could degrade dATP, dCTP, and dGTP with apparently similar facility to dTTP (Table   VII) . The activity against ATP or dTTP was inhibited only 10% by the nonspecific phosphatase substrate p-nitrophenylphosphate (5 mM) and was not inhibited by Ouabain (2 mM) . The specificity of this ecto-triphosphatase for triphosphates was demonstrated by the ability of the ATP analogue, y,,3 methylene ATP (5 mM) to inhibit both ATPase and dTTPase activity by 80%.
Ecto-triphosphatase activity was distinguishable from ecto-5'-nucleotidase activity. Ecto-triphosphatase activity was sensitive to inhibition by detergents. When Triton X-100 (0.1-0.5%) was added to the assay (Table VIII) . We have previously shown this analogue to inhibit ecto-5'-nucleotidase activity for both AMP and dTMP in these cell lines (20) . The influence ofdivalent cations on ecto-triphosphatase activity in an EBV-transformed B cell line was investigated by washing and resuspending the LAZ 007 line in a cation-free buffer. In a series of separate experiments, Ca++ and Mg++ ions were added at a concentration of 0.1-10 mM, using either ATP or dTTP as substrate. Dependence of the reaction on cation was demonstrated, and both ions were equally capable of restoring activity. Maximal activity was achieved at 0.5 mM, and this activity was not altered by increasing the cation concentration to 10 mM. The activity of ATPase and dTTPase at optimal Mg++ and Ca++ concentration was the same when assayed with cells suspended in culture medium, which contain Mg++ and Ca++. DISCUSSION The phenomenon of TdR growth inhibition at low concentration of exogenous TdR appears to reflect the ability of a cell to accumulate and sustain an increase system containing an intact, EBV-transformed B cell line, there was 80% inhibition of ATPase activity and complete inhibition of dTTPase activity. Similarly the detergent Nonidet P40 (0.25-1.0%) inhibited ATPase activity by 80% and dTTPase activity by 88%. Neither of these detergents inhibited the activity of ecto-5'-nucleotidase.
Furthermore, ecto-triphosphatase activity for ATP was not inhibited by mononucleotide substrates (AMP or TMP) of the ecto-5'-nucleotidase reaction. The ecto-triphosphatase activity for dTTP was not inhibited by TMP, but was partially inhibited by AMP (Table VIII) . The reason for this discrepancy is not apparent. The specific inhibitor of ecto-5'-nucleotidase,
did not inhibit ecto-triphosphatase activity using ATP as substrate but -20% when dTTP was substrate (5, 7) . They have shown cultured leukemic T cell lines to be deficient in ecto-5'-nucleotidase compared with high levels in EBV-transformed B lymphocyte lines, and have correlated these findings with deoxynucleoside sensitivity and resistance. We have confirmed these findings, and have reported that the cultured leukemic lymphocytes of null type which are deoxynucleoside sensitive have levels of ecto-5'-nucleotidase similar to those of resistant EBV-transformed B lymphocytes (20) ; however, the null type lymphocytes are deficient in ecto-triphosphatase activity. We have therefore inferred that ecto-5'-nucleotidase does not have a central role in determining deoxynucleoside sensitivity (20) .
The finding that cultured leukemic null lymphocytes, as distinct from the T lymphocytes, possess ecto-5'-nucleotidase while both are deficient in ecto-triphosphatase activity is consistent with the view that ecto-5'-nucleotidase and ecto-triphosphatase are distinct enzymes. This view is supported by (a) the destruction of ecto-triphosphatase activity but not ecto-5'-nucleotidase activity by detergent, (b) the failure of AMP or dTMP, substrates for the ecto-5'-nucleotidase, to inhibit ecto-triphosphatase activity, (c) activity of ecto-5'nucleotidase in the nanomolar range (5, 7, 20) compared with the micromolar range ofactivity ofectotriphosphatase. Further distinction between ecto-5'-nucleotidase and ecto-ATPase activities have been described by DePierre and Karnovsky (22 (12, 19, 23) . The biological role of ecto-(Ca++, Mg++)ATPase is obscure. The similarity of ecto-ATPase to muscle actomysin ATPase has suggested the possibility that ecto-ATPase contributes to plasma membrane function in cell contact and cell deformability (19) . The biological significance of its absence in leukemic T and null cells is apparently then more obscure. However, the possibility that low ecto-ATPase activity is related to some T cell function is suggested by histochemical studies of normal human lymph nodes and spleens demonstrating negative ATPase in T cell regions compared with positive B cell regions (25) . Furthermore, the ATPase activity of human peripheral blood B lymphocytes is higher than T lymphocytes (26) .
The apparent ability of ecto-ATPase to also degrade dNTP does not appear to have been previously reported. We have not unequivocally demonstrated a single enzyme to be responsible for this broad riboand dNTP specificity; however, the similarity in activity, effects of inhibitors, metal-ion requirement, and cell distributions suggests this may be so. The rapid and sustained accumulation of dNTP on exposure to deoxynucleosides correlates with growth inhibition and lack of ecto-triphosphatase activity. The way in which an ecto-triphosphatase could influence intracellular dNTP pool levels is not clear, however. It should be noted that Skoog and Bjursell (27) have shown during the GC phase ofthe cell cycle the largest amounts of dNTP are in the cytoplasm, whereas during S phase the relative amounts of dNTP in the nucleus increase. Could these phenomena and dNTP pools be controlled at the plasma membrane? There is little known about the possibility of an ecto-enzyme on the plasma membrane influencing levels of intracellular nucleotides by degradation. Thus, the possibility remains that the absence of triphosphatase activity in T lymphoblasts and null cells may be a marker for cells susceptible to deoxynucleoside toxicity rather than play a role in actual intracellular nucleotide metabolism. It should also be noted that the studies described in this report relate to cultured cell lines. Clearly, future investigations should be directed at T and B lymphocytes isolated directly from human blood and tissues. In particular, note that these cultured cell models represent distinct forms of transformation, i.e., leukemic and viral.
The similarity of the selective toxicity of TdR, GdR, and AdR for cultured T and null cells and the predominant T cell defect in ADA and PNP deficiency has been previously commented upon (5, 7). It appears necessary to invoke a biochemical phenomenon unique to T cells (and null cells) in addition to defects in deoxynucleoside catabolism -e.g., ADA deficiency, ADA inhibition by drugs, PNP deficiency, and TdR phosphorylase deficiency-to explain deoxynucleoside sensitivity (6) . If leukemic T and null lymphocytes mirror a particular stage in normal lymphocyte biochemical ontogeny, then ecto-triphosphatase deficiency may represent a biochemical mechanism common to the abnormality of lymphoid cell function in ADA and PNP deficiency. However the possibility that the manifestations of ADA deficiency are mediated by a nucleotide-independent process inactivation of Sadenosylhomocysteine hydrolase with accumulation of S-adenosylhomocysteine remains to be determined (28) .
